Results
|
|
281.
|
|
|
|
282.
|
|
|
|
283.
|
|
|
|
284.
|
|
|
|
285.
|
|
|
|
286.
|
|
|
|
287.
|
|
|
|
288.
|
|
|
|
289.
|
RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial. [electronic resource] by
- Lee, J L
- Kim, M K
- Park, I
- Ahn, J-H
- Lee, D H
- Ryoo, H M
- Song, C
- Hong, B
- Hong, J H
- Ahn, H
Producer: 20160818
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
290.
|
|
|
|
291.
|
|
|
|
292.
|
|
|
|
293.
|
Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China. [electronic resource] by
- Wang, Yuhong
- Jin, Kaizhou
- Tan, Huangying
- Zhang, Pan
- Yang, Qiuchen
- Wang, Wei
- Li, Jie
- Shao, Chenghao
- Xue, Ling
- Feng, Shiting
- Chen, Minhu
- Yu, Xianjun
- Chen, Jie
Producer: 20171227
In:
Cancer chemotherapy and pharmacology vol. 80
Availability: No items available.
|
|
|
294.
|
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial. [electronic resource] by
- Rini, Brian I
- Stenzl, Arnulf
- Zdrojowy, Romauld
- Kogan, Mikhail
- Shkolnik, Mikhail
- Oudard, Stephane
- Weikert, Steffen
- Bracarda, Sergio
- Crabb, Simon J
- Bedke, Jens
- Ludwig, Joerg
- Maurer, Dominik
- Mendrzyk, Regina
- Wagner, Claudia
- Mahr, Andrea
- Fritsche, Jens
- Weinschenk, Toni
- Walter, Steffen
- Kirner, Alexandra
- Singh-Jasuja, Harpreet
- Reinhardt, Carsten
- Eisen, Tim
Producer: 20170526
In:
The Lancet. Oncology vol. 17
Availability: No items available.
|
|
|
295.
|
|
|
|
296.
|
|
|
|
297.
|
|
|
|
298.
|
|
|
|
299.
|
|
|
|
300.
|
|